Testing the identity, integrity and labeling level of recombinant proteins Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E-Mail anzeigen Analysis of intact proteins by mass spectrometry W
Sequence Variant Analysis Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E-Mail anzeigen Identifying and quantifying errors in protein biosynthesis The presence of sequence variants (SV) c
Peptide Mapping Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E-Mail anzeigen Peptide mapping and determination of post-translational modifications of recombinant proteins (antibodies) Pe
Developability Assessment Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E-Mail anzeigen Development and stability studies of recombinant proteins (antibodies) Testing the developability o
Medical devices with direct or indirect patient contact are - for good reason - subject to strict rules for approval. It is therefore important particularly for SMEs to know whether their product is b
Services Dr. Nicole Schneiderhan-Marra Head of Pharma & Biotech +49 7121 51530-815 E-Mail anzeigen Dr. Markus Templin Group Leader Assay Development +49 7121 51530-828 E-Mail anzeigen Dr. Jens Göpfert
MIK - MDR- & IVDR-Competence Centre Dr. Hanna Hartmann Head of Biomedicine & Material Sciences +49 7121 51530-872 E-Mail anzeigen Dr. Xin Xiong Group Leader Biofunctionalized Surfaces +49 7121 51530-4
Media Library In our media library you will find our news archive, publications by our scientists, flyers on various topics, clips on our core competencies and the Paper Awards. NMI Best Paper Awards
Discover the future of biomedicine at the 3G-BioInk project meeting. Learn from leading minds about the latest advances funded by BMBF. At the second project meeting of the ambitious 3G-BioInk project